COVID-19

See how art collector turned immunologist James Crowe combines abstract thinking with game-changing technology to prevent infectious disease. Read More

Vanderbilt is committed to keeping the university community safe and informed. Information, resources and avenues of support are now available on the Health and Wellness website for people living with or caring for someone with Long COVID. Read More

Reporting Nov. 6 in Cell Reports Medicine, Ivelin Georgiev, PhD, and colleagues demonstrated that antibodies isolated from children’s blood samples displayed high levels of neutralization and potency against variants of the COVID-19 virus, SARS-CoV-2, even when the children had not previously been exposed to or vaccinated against those variants. Read More

Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes. Read More

A Vanderbilt-led study evaluating two investigational drugs to treat severe COVID-19 demonstrated that neither drug was effective. Read More

A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading. Read More

Two Vanderbilt faculty who conducted translational research have received the distinction of Best Invention of 2022 from TIME magazine. TIME’s Best Inventions of 2022 Cover “These winning innovations exemplify the transformative potential of university research when it aims to solve society’s most urgent problems, and when universities partner with the broader innovation ecosystem to bring... Read More

Two Vanderbilt faculty who conducted translational research have received the distinction of Best Invention of 2022 from TIME magazine. TIME’s Best Inventions of 2022 Cover “These winning innovations exemplify the transformative potential of university research when it aims to solve society’s most urgent problems, and when universities partner with the broader innovation ecosystem to bring... Read More

The School of Medicine Basic Sciences Dean’s Lecture featured renowned immunologist, virologist, and alumnus Dr. Barney S. Graham. In his talk, “Reflections on Pandemics and the Future of Medicine,” Graham discussed his early research experiences leading up to his seminal work on the first experimental COVID-19 vaccines, along with his observations on the pandemic and hopes for the future of medicine. Read More

A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age. Read More

Globally, at least 60% of countries proposed remote learning options that rely only on online platforms, but approximately 47% of students cannot connect to the internet from their homes. This Insights report analyzes factors affecting perceptions of government-provided distance learning during the pandemic. Read More

New Vanderbilt research explores the economic effects of pandemic-related migration patterns on municipal bonds. Read More

Moderna’s COVID-19 vaccine is safe and generates robust immune responses in children ages 6 to 11 years, a national clinical trial co-led by C. Buddy Creech, MD, MPH, has found. Read More

Vanderbilt research shows that the virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism.   Read More

Peter Buerhaus, PhD, FAAN, FAANP(h), a renowned researcher who studies the health care workforce and economy will share his expertise on the future of nursing, health equity and the relationship balance between nurses, leadership and educators. He will be the inaugural speaker in a new Leadership Lecture Series presented by the Vanderbilt University School of... Read More

New research from Vanderbilt Business highlights the importance of families, social workers, and chaplains to patient care. Read More

Gene variants increased the risk of acute kidney injury and death in veterans of African ancestry who were hospitalized with COVID-19, possibly explaining some health disparities associated with COVID-19. Read More

In my first year as chancellor, I witnessed the extraordinary efforts of everyone in the Vanderbilt community to carry on our mission of scholarship, creative expression and education despite the multiple challenges we faced. It was our proudest moment, but moreover, it clarified my initial impressions of the enduring strength of Vanderbilt’s culture. Read More

A new study found that several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the Omicron variant now sweeping across the United States. Read More

New research finds that fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death. Read More